FDA EUA has been submitted for SARS-CoV-2 kit, awaiting final clearance
Clinical trials initiated for the FDA submission for the Enteric Protozoan kit
Can now sell to select customers in the US under a
Section IVc exemption1 until FDA EUA is received - from the last investor presentation - I believe the end of November for the final clearance - hopefully - but short answer to your question - I am not sure
Confused, page-32
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.035(5.00%) |
Mkt cap ! $119.3M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 64.0¢ | $11.57K | 17.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10568 | 64.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.5¢ | 1030 | 2 |
View Market Depth
| Last trade - 13.52pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
65.5¢ |
Change
-0.035 ( 5.76 %) |
||||
| Open | High | Low | Volume | ||
| 69.5¢ | 70.0¢ | 65.5¢ | 6250 | ||
| Last updated 13.52pm 30/04/2024 ? | |||||
| GSS (ASX) Chart |